nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Methotrexate—systemic lupus erythematosus	0.419	1	CrCtD
Pralatrexate—SLC19A1—Methotrexate—systemic lupus erythematosus	0.11	0.426	CbGbCtD
Pralatrexate—FPGS—Methotrexate—systemic lupus erythematosus	0.0794	0.308	CbGbCtD
Pralatrexate—Leucovorin—Methotrexate—systemic lupus erythematosus	0.0554	0.2	CrCrCtD
Pralatrexate—Tetrahydrofolic acid—Methotrexate—systemic lupus erythematosus	0.0554	0.2	CrCrCtD
Pralatrexate—Folic Acid—Methotrexate—systemic lupus erythematosus	0.0554	0.2	CrCrCtD
Pralatrexate—Raltitrexed—Methotrexate—systemic lupus erythematosus	0.0554	0.2	CrCrCtD
Pralatrexate—Pemetrexed—Methotrexate—systemic lupus erythematosus	0.0554	0.2	CrCrCtD
Pralatrexate—DHFR—Methotrexate—systemic lupus erythematosus	0.0403	0.156	CbGbCtD
Pralatrexate—TYMS—Methotrexate—systemic lupus erythematosus	0.0281	0.109	CbGbCtD
Pralatrexate—SLC19A1—lymphoid tissue—systemic lupus erythematosus	0.00116	0.0571	CbGeAlD
Pralatrexate—FPGS—connective tissue—systemic lupus erythematosus	0.00106	0.052	CbGeAlD
Pralatrexate—SLC19A1—lung—systemic lupus erythematosus	0.000961	0.0471	CbGeAlD
Pralatrexate—FPGS—skin of body—systemic lupus erythematosus	0.000958	0.0469	CbGeAlD
Pralatrexate—SLC19A1—nervous system—systemic lupus erythematosus	0.00089	0.0436	CbGeAlD
Pralatrexate—FPGS—cortex of kidney—systemic lupus erythematosus	0.00088	0.0431	CbGeAlD
Pralatrexate—SLC19A1—central nervous system—systemic lupus erythematosus	0.000857	0.042	CbGeAlD
Pralatrexate—FPGS—lymphoid tissue—systemic lupus erythematosus	0.000776	0.038	CbGeAlD
Pralatrexate—FPGS—tendon—systemic lupus erythematosus	0.000729	0.0357	CbGeAlD
Pralatrexate—TYMS—connective tissue—systemic lupus erythematosus	0.000696	0.0341	CbGeAlD
Pralatrexate—DHFR—connective tissue—systemic lupus erythematosus	0.000689	0.0338	CbGeAlD
Pralatrexate—TYMS—nephron tubule—systemic lupus erythematosus	0.000674	0.033	CbGeAlD
Pralatrexate—DHFR—nephron tubule—systemic lupus erythematosus	0.000668	0.0327	CbGeAlD
Pralatrexate—FPGS—lung—systemic lupus erythematosus	0.00064	0.0314	CbGeAlD
Pralatrexate—TYMS—skin of body—systemic lupus erythematosus	0.000629	0.0308	CbGeAlD
Pralatrexate—DHFR—Nucleotide Metabolism—POLB—systemic lupus erythematosus	0.000622	0.126	CbGpPWpGaD
Pralatrexate—FPGS—nervous system—systemic lupus erythematosus	0.000593	0.029	CbGeAlD
Pralatrexate—DHFR—kidney—systemic lupus erythematosus	0.000587	0.0287	CbGeAlD
Pralatrexate—TYMS—cortex of kidney—systemic lupus erythematosus	0.000577	0.0283	CbGeAlD
Pralatrexate—DHFR—cortex of kidney—systemic lupus erythematosus	0.000571	0.028	CbGeAlD
Pralatrexate—FPGS—central nervous system—systemic lupus erythematosus	0.000571	0.028	CbGeAlD
Pralatrexate—TYMS—lymphoid tissue—systemic lupus erythematosus	0.000509	0.0249	CbGeAlD
Pralatrexate—DHFR—lymphoid tissue—systemic lupus erythematosus	0.000504	0.0247	CbGeAlD
Pralatrexate—TYMS—tendon—systemic lupus erythematosus	0.000479	0.0234	CbGeAlD
Pralatrexate—DHFR—tendon—systemic lupus erythematosus	0.000474	0.0232	CbGeAlD
Pralatrexate—TYMS—bone marrow—systemic lupus erythematosus	0.000463	0.0227	CbGeAlD
Pralatrexate—Tumour lysis syndrome—Methotrexate—systemic lupus erythematosus	0.000459	0.0243	CcSEcCtD
Pralatrexate—DHFR—bone marrow—systemic lupus erythematosus	0.000459	0.0225	CbGeAlD
Pralatrexate—Night sweats—Cyclosporine—systemic lupus erythematosus	0.000428	0.0226	CcSEcCtD
Pralatrexate—TYMS—lung—systemic lupus erythematosus	0.00042	0.0206	CbGeAlD
Pralatrexate—DHFR—lung—systemic lupus erythematosus	0.000416	0.0204	CbGeAlD
Pralatrexate—TYMS—nervous system—systemic lupus erythematosus	0.000389	0.0191	CbGeAlD
Pralatrexate—DHFR—nervous system—systemic lupus erythematosus	0.000385	0.0189	CbGeAlD
Pralatrexate—TYMS—central nervous system—systemic lupus erythematosus	0.000374	0.0183	CbGeAlD
Pralatrexate—Neoplasm malignant—Azathioprine—systemic lupus erythematosus	0.000371	0.0196	CcSEcCtD
Pralatrexate—DHFR—central nervous system—systemic lupus erythematosus	0.000371	0.0182	CbGeAlD
Pralatrexate—Neoplasm malignant—Cyclosporine—systemic lupus erythematosus	0.00027	0.0143	CcSEcCtD
Pralatrexate—Sepsis—Leflunomide—systemic lupus erythematosus	0.000259	0.0137	CcSEcCtD
Pralatrexate—Cough—Dapsone—systemic lupus erythematosus	0.000214	0.0113	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Azathioprine—systemic lupus erythematosus	0.000207	0.011	CcSEcCtD
Pralatrexate—Liver function test abnormal—Leflunomide—systemic lupus erythematosus	0.0002	0.0106	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL4—systemic lupus erythematosus	0.0002	0.0405	CbGpPWpGaD
Pralatrexate—Sepsis—Cyclosporine—systemic lupus erythematosus	0.0002	0.0106	CcSEcCtD
Pralatrexate—Hypokalaemia—Leflunomide—systemic lupus erythematosus	0.000198	0.0105	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Leflunomide—systemic lupus erythematosus	0.000195	0.0104	CcSEcCtD
Pralatrexate—Sepsis—Mycophenolate mofetil—systemic lupus erythematosus	0.000195	0.0103	CcSEcCtD
Pralatrexate—Tachycardia—Dapsone—systemic lupus erythematosus	0.000195	0.0103	CcSEcCtD
Pralatrexate—Pancytopenia—Azathioprine—systemic lupus erythematosus	0.000189	0.00999	CcSEcCtD
Pralatrexate—Pancytopenia—Leflunomide—systemic lupus erythematosus	0.000178	0.00944	CcSEcCtD
Pralatrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—systemic lupus erythematosus	0.000176	0.0357	CbGpPWpGaD
Pralatrexate—Neutropenia—Leflunomide—systemic lupus erythematosus	0.000175	0.00929	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Leflunomide—systemic lupus erythematosus	0.000174	0.00923	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—CRP—systemic lupus erythematosus	0.000173	0.035	CbGpPWpGaD
Pralatrexate—Gastrointestinal pain—Dapsone—systemic lupus erythematosus	0.000163	0.00865	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—F2—systemic lupus erythematosus	0.00016	0.0323	CbGpPWpGaD
Pralatrexate—Abdominal pain—Dapsone—systemic lupus erythematosus	0.000158	0.00836	CcSEcCtD
Pralatrexate—Body temperature increased—Dapsone—systemic lupus erythematosus	0.000158	0.00836	CcSEcCtD
Pralatrexate—Epistaxis—Leflunomide—systemic lupus erythematosus	0.000158	0.00836	CcSEcCtD
Pralatrexate—Dehydration—Mycophenolate mofetil—systemic lupus erythematosus	0.000152	0.00805	CcSEcCtD
Pralatrexate—Liver function test abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000151	0.00799	CcSEcCtD
Pralatrexate—Hypokalaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.00788	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—CCL2—systemic lupus erythematosus	0.000142	0.0288	CbGpPWpGaD
Pralatrexate—Hypokalaemia—Hydrocortisone—systemic lupus erythematosus	0.000135	0.00718	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Cyclosporine—systemic lupus erythematosus	0.000135	0.00713	CcSEcCtD
Pralatrexate—Pancytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.0071	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—ALB—systemic lupus erythematosus	0.000133	0.0269	CbGpPWpGaD
Pralatrexate—Sepsis—Prednisone—systemic lupus erythematosus	0.000132	0.00701	CcSEcCtD
Pralatrexate—Neutropenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000132	0.00699	CcSEcCtD
Pralatrexate—Anaemia—Azathioprine—systemic lupus erythematosus	0.000128	0.00678	CcSEcCtD
Pralatrexate—Vomiting—Dapsone—systemic lupus erythematosus	0.000127	0.00673	CcSEcCtD
Pralatrexate—Back pain—Leflunomide—systemic lupus erythematosus	0.000126	0.0067	CcSEcCtD
Pralatrexate—Leukopenia—Azathioprine—systemic lupus erythematosus	0.000124	0.00656	CcSEcCtD
Pralatrexate—DHFR—Metabolism of nitric oxide—NOS3—systemic lupus erythematosus	0.000122	0.0247	CbGpPWpGaD
Pralatrexate—Epistaxis—Cyclosporine—systemic lupus erythematosus	0.000122	0.00645	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IFNG—systemic lupus erythematosus	0.000121	0.0245	CbGpPWpGaD
Pralatrexate—Anaemia—Leflunomide—systemic lupus erythematosus	0.000121	0.0064	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Hydrocortisone—systemic lupus erythematosus	0.00012	0.00633	CcSEcCtD
Pralatrexate—Epistaxis—Mycophenolate mofetil—systemic lupus erythematosus	0.000119	0.00629	CcSEcCtD
Pralatrexate—Nausea—Dapsone—systemic lupus erythematosus	0.000119	0.00628	CcSEcCtD
Pralatrexate—Leukopenia—Leflunomide—systemic lupus erythematosus	0.000117	0.0062	CcSEcCtD
Pralatrexate—Hypokalaemia—Betamethasone—systemic lupus erythematosus	0.000116	0.00613	CcSEcCtD
Pralatrexate—Hypokalaemia—Dexamethasone—systemic lupus erythematosus	0.000116	0.00613	CcSEcCtD
Pralatrexate—Cough—Leflunomide—systemic lupus erythematosus	0.000114	0.00604	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Triamcinolone—systemic lupus erythematosus	0.000113	0.00596	CcSEcCtD
Pralatrexate—Sepsis—Methotrexate—systemic lupus erythematosus	0.000111	0.00586	CcSEcCtD
Pralatrexate—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000111	0.00586	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL2—systemic lupus erythematosus	0.000108	0.0218	CbGpPWpGaD
Pralatrexate—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000104	0.00553	CcSEcCtD
Pralatrexate—Tachycardia—Leflunomide—systemic lupus erythematosus	0.000104	0.00551	CcSEcCtD
Pralatrexate—Epistaxis—Triamcinolone—systemic lupus erythematosus	0.000102	0.0054	CcSEcCtD
Pralatrexate—Anorexia—Leflunomide—systemic lupus erythematosus	0.000102	0.00539	CcSEcCtD
Pralatrexate—Hypokalaemia—Prednisone—systemic lupus erythematosus	0.000101	0.00534	CcSEcCtD
Pralatrexate—Back pain—Mycophenolate mofetil—systemic lupus erythematosus	9.52e-05	0.00504	CcSEcCtD
Pralatrexate—Dyspnoea—Leflunomide—systemic lupus erythematosus	9.51e-05	0.00504	CcSEcCtD
Pralatrexate—Anaemia—Cyclosporine—systemic lupus erythematosus	9.32e-05	0.00494	CcSEcCtD
Pralatrexate—SLC19A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—systemic lupus erythematosus	9.3e-05	0.0188	CbGpPWpGaD
Pralatrexate—Decreased appetite—Leflunomide—systemic lupus erythematosus	9.27e-05	0.00491	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Azathioprine—systemic lupus erythematosus	9.24e-05	0.00489	CcSEcCtD
Pralatrexate—Fatigue—Leflunomide—systemic lupus erythematosus	9.2e-05	0.00487	CcSEcCtD
Pralatrexate—Constipation—Leflunomide—systemic lupus erythematosus	9.12e-05	0.00483	CcSEcCtD
Pralatrexate—Anaemia—Mycophenolate mofetil—systemic lupus erythematosus	9.1e-05	0.00482	CcSEcCtD
Pralatrexate—Leukopenia—Cyclosporine—systemic lupus erythematosus	9.03e-05	0.00478	CcSEcCtD
Pralatrexate—Neutropenia—Prednisone—systemic lupus erythematosus	8.95e-05	0.00474	CcSEcCtD
Pralatrexate—Abdominal pain—Azathioprine—systemic lupus erythematosus	8.93e-05	0.00473	CcSEcCtD
Pralatrexate—Body temperature increased—Azathioprine—systemic lupus erythematosus	8.93e-05	0.00473	CcSEcCtD
Pralatrexate—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	8.81e-05	0.00467	CcSEcCtD
Pralatrexate—Cough—Cyclosporine—systemic lupus erythematosus	8.8e-05	0.00466	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	8.72e-05	0.00462	CcSEcCtD
Pralatrexate—Cough—Mycophenolate mofetil—systemic lupus erythematosus	8.59e-05	0.00455	CcSEcCtD
Pralatrexate—Liver function test abnormal—Methotrexate—systemic lupus erythematosus	8.55e-05	0.00453	CcSEcCtD
Pralatrexate—Abdominal pain—Leflunomide—systemic lupus erythematosus	8.43e-05	0.00447	CcSEcCtD
Pralatrexate—Body temperature increased—Leflunomide—systemic lupus erythematosus	8.43e-05	0.00447	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	8.34e-05	0.00441	CcSEcCtD
Pralatrexate—Oedema—Cyclosporine—systemic lupus erythematosus	8.23e-05	0.00436	CcSEcCtD
Pralatrexate—Back pain—Triamcinolone—systemic lupus erythematosus	8.17e-05	0.00432	CcSEcCtD
Pralatrexate—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	8.06e-05	0.00427	CcSEcCtD
Pralatrexate—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	8.03e-05	0.00425	CcSEcCtD
Pralatrexate—FPGS—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—systemic lupus erythematosus	7.91e-05	0.016	CbGpPWpGaD
Pralatrexate—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	7.86e-05	0.00416	CcSEcCtD
Pralatrexate—Anorexia—Cyclosporine—systemic lupus erythematosus	7.85e-05	0.00416	CcSEcCtD
Pralatrexate—Tachycardia—Mycophenolate mofetil—systemic lupus erythematosus	7.84e-05	0.00415	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—TNF—systemic lupus erythematosus	7.84e-05	0.0159	CbGpPWpGaD
Pralatrexate—Diarrhoea—Azathioprine—systemic lupus erythematosus	7.73e-05	0.00409	CcSEcCtD
Pralatrexate—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	7.66e-05	0.00405	CcSEcCtD
Pralatrexate—Asthenia—Leflunomide—systemic lupus erythematosus	7.65e-05	0.00405	CcSEcCtD
Pralatrexate—Pancytopenia—Methotrexate—systemic lupus erythematosus	7.6e-05	0.00402	CcSEcCtD
Pralatrexate—Pruritus—Leflunomide—systemic lupus erythematosus	7.55e-05	0.004	CcSEcCtD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	7.54e-05	0.0153	CbGpPWpGaD
Pralatrexate—Oedema—Prednisolone—systemic lupus erythematosus	7.49e-05	0.00397	CcSEcCtD
Pralatrexate—Neutropenia—Methotrexate—systemic lupus erythematosus	7.48e-05	0.00396	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	7.44e-05	0.00394	CcSEcCtD
Pralatrexate—Cough—Triamcinolone—systemic lupus erythematosus	7.37e-05	0.0039	CcSEcCtD
Pralatrexate—Dyspnoea—Cyclosporine—systemic lupus erythematosus	7.34e-05	0.00389	CcSEcCtD
Pralatrexate—Oedema—Hydrocortisone—systemic lupus erythematosus	7.32e-05	0.00388	CcSEcCtD
Pralatrexate—Tachycardia—Prednisolone—systemic lupus erythematosus	7.31e-05	0.00387	CcSEcCtD
Pralatrexate—Diarrhoea—Leflunomide—systemic lupus erythematosus	7.3e-05	0.00387	CcSEcCtD
Pralatrexate—Vomiting—Azathioprine—systemic lupus erythematosus	7.18e-05	0.0038	CcSEcCtD
Pralatrexate—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	7.16e-05	0.00379	CcSEcCtD
Pralatrexate—Decreased appetite—Cyclosporine—systemic lupus erythematosus	7.16e-05	0.00379	CcSEcCtD
Pralatrexate—Tachycardia—Hydrocortisone—systemic lupus erythematosus	7.14e-05	0.00378	CcSEcCtD
Pralatrexate—Rash—Azathioprine—systemic lupus erythematosus	7.12e-05	0.00377	CcSEcCtD
Pralatrexate—Dermatitis—Azathioprine—systemic lupus erythematosus	7.12e-05	0.00377	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—IL4—systemic lupus erythematosus	7.11e-05	0.0144	CbGpPWpGaD
Pralatrexate—Fatigue—Cyclosporine—systemic lupus erythematosus	7.1e-05	0.00376	CcSEcCtD
Pralatrexate—Constipation—Cyclosporine—systemic lupus erythematosus	7.04e-05	0.00373	CcSEcCtD
Pralatrexate—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	6.98e-05	0.0037	CcSEcCtD
Pralatrexate—Anorexia—Hydrocortisone—systemic lupus erythematosus	6.98e-05	0.00369	CcSEcCtD
Pralatrexate—Oedema—Triamcinolone—systemic lupus erythematosus	6.89e-05	0.00365	CcSEcCtD
Pralatrexate—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	6.87e-05	0.00364	CcSEcCtD
Pralatrexate—Vomiting—Leflunomide—systemic lupus erythematosus	6.78e-05	0.00359	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	6.73e-05	0.00357	CcSEcCtD
Pralatrexate—Epistaxis—Methotrexate—systemic lupus erythematosus	6.73e-05	0.00356	CcSEcCtD
Pralatrexate—Rash—Leflunomide—systemic lupus erythematosus	6.73e-05	0.00356	CcSEcCtD
Pralatrexate—Tachycardia—Triamcinolone—systemic lupus erythematosus	6.72e-05	0.00356	CcSEcCtD
Pralatrexate—Dermatitis—Leflunomide—systemic lupus erythematosus	6.72e-05	0.00356	CcSEcCtD
Pralatrexate—Nausea—Azathioprine—systemic lupus erythematosus	6.71e-05	0.00355	CcSEcCtD
Pralatrexate—Tachycardia—Methylprednisolone—systemic lupus erythematosus	6.71e-05	0.00355	CcSEcCtD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	6.58e-05	0.0133	CbGpPWpGaD
Pralatrexate—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.57e-05	0.00348	CcSEcCtD
Pralatrexate—Abdominal pain—Cyclosporine—systemic lupus erythematosus	6.51e-05	0.00345	CcSEcCtD
Pralatrexate—Body temperature increased—Cyclosporine—systemic lupus erythematosus	6.51e-05	0.00345	CcSEcCtD
Pralatrexate—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	6.36e-05	0.00337	CcSEcCtD
Pralatrexate—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	6.35e-05	0.00336	CcSEcCtD
Pralatrexate—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	6.35e-05	0.00336	CcSEcCtD
Pralatrexate—Nausea—Leflunomide—systemic lupus erythematosus	6.34e-05	0.00336	CcSEcCtD
Pralatrexate—SLC19A1—Folate Metabolism—IL6—systemic lupus erythematosus	6.32e-05	0.0128	CbGpPWpGaD
Pralatrexate—Fatigue—Hydrocortisone—systemic lupus erythematosus	6.31e-05	0.00334	CcSEcCtD
Pralatrexate—Oedema—Betamethasone—systemic lupus erythematosus	6.25e-05	0.00331	CcSEcCtD
Pralatrexate—Oedema—Dexamethasone—systemic lupus erythematosus	6.25e-05	0.00331	CcSEcCtD
Pralatrexate—Anaemia—Prednisone—systemic lupus erythematosus	6.17e-05	0.00327	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—CRP—systemic lupus erythematosus	6.15e-05	0.0124	CbGpPWpGaD
Pralatrexate—Dyspnoea—Triamcinolone—systemic lupus erythematosus	6.14e-05	0.00325	CcSEcCtD
Pralatrexate—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	6.12e-05	0.00324	CcSEcCtD
Pralatrexate—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	6.12e-05	0.00324	CcSEcCtD
Pralatrexate—Tachycardia—Dexamethasone—systemic lupus erythematosus	6.1e-05	0.00323	CcSEcCtD
Pralatrexate—Tachycardia—Betamethasone—systemic lupus erythematosus	6.1e-05	0.00323	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	5.98e-05	0.00317	CcSEcCtD
Pralatrexate—Anorexia—Betamethasone—systemic lupus erythematosus	5.96e-05	0.00316	CcSEcCtD
Pralatrexate—Anorexia—Dexamethasone—systemic lupus erythematosus	5.96e-05	0.00316	CcSEcCtD
Pralatrexate—Fatigue—Triamcinolone—systemic lupus erythematosus	5.94e-05	0.00315	CcSEcCtD
Pralatrexate—Fatigue—Methylprednisolone—systemic lupus erythematosus	5.93e-05	0.00314	CcSEcCtD
Pralatrexate—Asthenia—Cyclosporine—systemic lupus erythematosus	5.91e-05	0.00313	CcSEcCtD
Pralatrexate—Pruritus—Cyclosporine—systemic lupus erythematosus	5.83e-05	0.00308	CcSEcCtD
Pralatrexate—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	5.78e-05	0.00306	CcSEcCtD
Pralatrexate—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	5.78e-05	0.00306	CcSEcCtD
Pralatrexate—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	5.76e-05	0.00305	CcSEcCtD
Pralatrexate—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	5.68e-05	0.00301	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—F2—systemic lupus erythematosus	5.67e-05	0.0115	CbGpPWpGaD
Pralatrexate—Diarrhoea—Cyclosporine—systemic lupus erythematosus	5.63e-05	0.00298	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	5.62e-05	0.00298	CcSEcCtD
Pralatrexate—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	5.5e-05	0.00291	CcSEcCtD
Pralatrexate—Body temperature increased—Triamcinolone—systemic lupus erythematosus	5.45e-05	0.00288	CcSEcCtD
Pralatrexate—Oedema—Prednisone—systemic lupus erythematosus	5.44e-05	0.00288	CcSEcCtD
Pralatrexate—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	5.43e-05	0.00288	CcSEcCtD
Pralatrexate—Decreased appetite—Dexamethasone—systemic lupus erythematosus	5.43e-05	0.00288	CcSEcCtD
Pralatrexate—Decreased appetite—Betamethasone—systemic lupus erythematosus	5.43e-05	0.00288	CcSEcCtD
Pralatrexate—Back pain—Methotrexate—systemic lupus erythematosus	5.39e-05	0.00286	CcSEcCtD
Pralatrexate—Fatigue—Dexamethasone—systemic lupus erythematosus	5.39e-05	0.00285	CcSEcCtD
Pralatrexate—Fatigue—Betamethasone—systemic lupus erythematosus	5.39e-05	0.00285	CcSEcCtD
Pralatrexate—Tachycardia—Prednisone—systemic lupus erythematosus	5.31e-05	0.00281	CcSEcCtD
Pralatrexate—Asthenia—Hydrocortisone—systemic lupus erythematosus	5.25e-05	0.00278	CcSEcCtD
Pralatrexate—Vomiting—Cyclosporine—systemic lupus erythematosus	5.24e-05	0.00277	CcSEcCtD
Pralatrexate—Rash—Cyclosporine—systemic lupus erythematosus	5.19e-05	0.00275	CcSEcCtD
Pralatrexate—Anorexia—Prednisone—systemic lupus erythematosus	5.19e-05	0.00275	CcSEcCtD
Pralatrexate—Dermatitis—Cyclosporine—systemic lupus erythematosus	5.19e-05	0.00275	CcSEcCtD
Pralatrexate—Pruritus—Hydrocortisone—systemic lupus erythematosus	5.18e-05	0.00274	CcSEcCtD
Pralatrexate—Anaemia—Methotrexate—systemic lupus erythematosus	5.15e-05	0.00273	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	5.11e-05	0.00271	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	5.11e-05	0.00271	CcSEcCtD
Pralatrexate—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	5.11e-05	0.0027	CcSEcCtD
Pralatrexate—Rash—Mycophenolate mofetil—systemic lupus erythematosus	5.06e-05	0.00268	CcSEcCtD
Pralatrexate—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	5.06e-05	0.00268	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—CCL2—systemic lupus erythematosus	5.06e-05	0.0102	CbGpPWpGaD
Pralatrexate—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	5.01e-05	0.00265	CcSEcCtD
Pralatrexate—Leukopenia—Methotrexate—systemic lupus erythematosus	4.99e-05	0.00264	CcSEcCtD
Pralatrexate—Asthenia—Triamcinolone—systemic lupus erythematosus	4.94e-05	0.00262	CcSEcCtD
Pralatrexate—Body temperature increased—Betamethasone—systemic lupus erythematosus	4.94e-05	0.00262	CcSEcCtD
Pralatrexate—Body temperature increased—Dexamethasone—systemic lupus erythematosus	4.94e-05	0.00262	CcSEcCtD
Pralatrexate—Abdominal pain—Dexamethasone—systemic lupus erythematosus	4.94e-05	0.00262	CcSEcCtD
Pralatrexate—Abdominal pain—Betamethasone—systemic lupus erythematosus	4.94e-05	0.00262	CcSEcCtD
Pralatrexate—Asthenia—Methylprednisolone—systemic lupus erythematosus	4.93e-05	0.00261	CcSEcCtD
Pralatrexate—SLC19A1—Disease—XRCC6—systemic lupus erythematosus	4.91e-05	0.00993	CbGpPWpGaD
Pralatrexate—Nausea—Cyclosporine—systemic lupus erythematosus	4.89e-05	0.00259	CcSEcCtD
Pralatrexate—Pruritus—Triamcinolone—systemic lupus erythematosus	4.87e-05	0.00258	CcSEcCtD
Pralatrexate—Cough—Methotrexate—systemic lupus erythematosus	4.86e-05	0.00258	CcSEcCtD
Pralatrexate—Pruritus—Methylprednisolone—systemic lupus erythematosus	4.86e-05	0.00258	CcSEcCtD
Pralatrexate—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	4.77e-05	0.00253	CcSEcCtD
Pralatrexate—Decreased appetite—Prednisone—systemic lupus erythematosus	4.73e-05	0.00251	CcSEcCtD
Pralatrexate—Rash—Prednisolone—systemic lupus erythematosus	4.72e-05	0.0025	CcSEcCtD
Pralatrexate—Dermatitis—Prednisolone—systemic lupus erythematosus	4.72e-05	0.0025	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—ALB—systemic lupus erythematosus	4.71e-05	0.00954	CbGpPWpGaD
Pralatrexate—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	4.7e-05	0.00249	CcSEcCtD
Pralatrexate—Fatigue—Prednisone—systemic lupus erythematosus	4.69e-05	0.00249	CcSEcCtD
Pralatrexate—Constipation—Prednisone—systemic lupus erythematosus	4.66e-05	0.00247	CcSEcCtD
Pralatrexate—Vomiting—Hydrocortisone—systemic lupus erythematosus	4.65e-05	0.00246	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Hydrocortisone—systemic lupus erythematosus	4.62e-05	0.0303	CbGdCrCtD
Pralatrexate—Rash—Hydrocortisone—systemic lupus erythematosus	4.61e-05	0.00244	CcSEcCtD
Pralatrexate—Dermatitis—Hydrocortisone—systemic lupus erythematosus	4.61e-05	0.00244	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Hydrocortisone—systemic lupus erythematosus	4.58e-05	0.03	CbGdCrCtD
Pralatrexate—Asthenia—Dexamethasone—systemic lupus erythematosus	4.49e-05	0.00238	CcSEcCtD
Pralatrexate—Asthenia—Betamethasone—systemic lupus erythematosus	4.49e-05	0.00238	CcSEcCtD
Pralatrexate—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	4.45e-05	0.00236	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	4.45e-05	0.00236	CcSEcCtD
Pralatrexate—Nausea—Prednisolone—systemic lupus erythematosus	4.45e-05	0.00236	CcSEcCtD
Pralatrexate—Pruritus—Dexamethasone—systemic lupus erythematosus	4.42e-05	0.00234	CcSEcCtD
Pralatrexate—Pruritus—Betamethasone—systemic lupus erythematosus	4.42e-05	0.00234	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Methylprednisolone—systemic lupus erythematosus	4.42e-05	0.029	CbGdCrCtD
Pralatrexate—Vomiting—Triamcinolone—systemic lupus erythematosus	4.38e-05	0.00232	CcSEcCtD
Pralatrexate—Vomiting—Methylprednisolone—systemic lupus erythematosus	4.37e-05	0.00231	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Methylprednisolone—systemic lupus erythematosus	4.36e-05	0.0286	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Betamethasone—systemic lupus erythematosus	4.35e-05	0.0286	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Dexamethasone—systemic lupus erythematosus	4.35e-05	0.0286	CbGdCrCtD
Pralatrexate—Nausea—Hydrocortisone—systemic lupus erythematosus	4.35e-05	0.0023	CcSEcCtD
Pralatrexate—Rash—Triamcinolone—systemic lupus erythematosus	4.34e-05	0.0023	CcSEcCtD
Pralatrexate—Dermatitis—Triamcinolone—systemic lupus erythematosus	4.34e-05	0.0023	CcSEcCtD
Pralatrexate—Anorexia—Methotrexate—systemic lupus erythematosus	4.34e-05	0.0023	CcSEcCtD
Pralatrexate—Rash—Methylprednisolone—systemic lupus erythematosus	4.33e-05	0.0023	CcSEcCtD
Pralatrexate—Dermatitis—Methylprednisolone—systemic lupus erythematosus	4.33e-05	0.00229	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Methylprednisolone—systemic lupus erythematosus	4.32e-05	0.0283	CbGdCrCtD
Pralatrexate—Body temperature increased—Prednisone—systemic lupus erythematosus	4.3e-05	0.00228	CcSEcCtD
Pralatrexate—Abdominal pain—Prednisone—systemic lupus erythematosus	4.3e-05	0.00228	CcSEcCtD
Pralatrexate—DHFR—Folate Metabolism—IFNG—systemic lupus erythematosus	4.3e-05	0.0087	CbGpPWpGaD
Pralatrexate—TYMS—Flunisolide—Betamethasone—systemic lupus erythematosus	4.29e-05	0.0282	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Dexamethasone—systemic lupus erythematosus	4.29e-05	0.0282	CbGdCrCtD
Pralatrexate—Diarrhoea—Dexamethasone—systemic lupus erythematosus	4.28e-05	0.00227	CcSEcCtD
Pralatrexate—Diarrhoea—Betamethasone—systemic lupus erythematosus	4.28e-05	0.00227	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Triamcinolone—systemic lupus erythematosus	4.25e-05	0.0279	CbGdCrCtD
Pralatrexate—TYMS—Triamcinolone—Betamethasone—systemic lupus erythematosus	4.25e-05	0.0279	CbGdCrCtD
Pralatrexate—TYMS—Triamcinolone—Dexamethasone—systemic lupus erythematosus	4.25e-05	0.0279	CbGdCrCtD
Pralatrexate—TYMS—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	4.21e-05	0.0276	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Triamcinolone—systemic lupus erythematosus	4.19e-05	0.0275	CbGdCrCtD
Pralatrexate—FPGS—Disease—XRCC6—systemic lupus erythematosus	4.17e-05	0.00845	CbGpPWpGaD
Pralatrexate—TYMS—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	4.14e-05	0.0272	CbGdCrCtD
Pralatrexate—TYMS—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	4.14e-05	0.0272	CbGdCrCtD
Pralatrexate—Nausea—Triamcinolone—systemic lupus erythematosus	4.09e-05	0.00217	CcSEcCtD
Pralatrexate—Nausea—Methylprednisolone—systemic lupus erythematosus	4.08e-05	0.00216	CcSEcCtD
Pralatrexate—Dyspnoea—Methotrexate—systemic lupus erythematosus	4.06e-05	0.00215	CcSEcCtD
Pralatrexate—TYMS—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	4.05e-05	0.0266	CbGdCrCtD
Pralatrexate—TYMS—Clobetasol propionate—Prednisone—systemic lupus erythematosus	4.03e-05	0.0265	CbGdCrCtD
Pralatrexate—TYMS—Flunisolide—Prednisone—systemic lupus erythematosus	3.98e-05	0.0261	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Methylprednisolone—systemic lupus erythematosus	3.98e-05	0.0261	CbGdCrCtD
Pralatrexate—Vomiting—Betamethasone—systemic lupus erythematosus	3.97e-05	0.00211	CcSEcCtD
Pralatrexate—Vomiting—Dexamethasone—systemic lupus erythematosus	3.97e-05	0.00211	CcSEcCtD
Pralatrexate—Decreased appetite—Methotrexate—systemic lupus erythematosus	3.96e-05	0.00209	CcSEcCtD
Pralatrexate—Rash—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.00209	CcSEcCtD
Pralatrexate—Rash—Betamethasone—systemic lupus erythematosus	3.94e-05	0.00209	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Prednisone—systemic lupus erythematosus	3.94e-05	0.0259	CbGdCrCtD
Pralatrexate—Dermatitis—Betamethasone—systemic lupus erythematosus	3.94e-05	0.00209	CcSEcCtD
Pralatrexate—Dermatitis—Dexamethasone—systemic lupus erythematosus	3.94e-05	0.00209	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Prednisolone—systemic lupus erythematosus	3.94e-05	0.0258	CbGdCrCtD
Pralatrexate—Fatigue—Methotrexate—systemic lupus erythematosus	3.92e-05	0.00208	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.0257	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Betamethasone—systemic lupus erythematosus	3.92e-05	0.0257	CbGdCrCtD
Pralatrexate—Asthenia—Prednisone—systemic lupus erythematosus	3.91e-05	0.00207	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Prednisolone—systemic lupus erythematosus	3.89e-05	0.0255	CbGdCrCtD
Pralatrexate—Pruritus—Prednisone—systemic lupus erythematosus	3.85e-05	0.00204	CcSEcCtD
Pralatrexate—TYMS—Triamcinolone—Prednisolone—systemic lupus erythematosus	3.85e-05	0.0252	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Triamcinolone—systemic lupus erythematosus	3.83e-05	0.0251	CbGdCrCtD
Pralatrexate—DHFR—Folate Metabolism—IL2—systemic lupus erythematosus	3.82e-05	0.00773	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	3.75e-05	0.00758	CbGpPWpGaD
Pralatrexate—Diarrhoea—Prednisone—systemic lupus erythematosus	3.73e-05	0.00197	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	3.72e-05	0.00197	CcSEcCtD
Pralatrexate—Nausea—Betamethasone—systemic lupus erythematosus	3.71e-05	0.00197	CcSEcCtD
Pralatrexate—Nausea—Dexamethasone—systemic lupus erythematosus	3.71e-05	0.00197	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.0243	CbGdCrCtD
Pralatrexate—TYMS—Diflorasone—Prednisone—systemic lupus erythematosus	3.63e-05	0.0238	CbGdCrCtD
Pralatrexate—SLC19A1—Disease—HIST2H2AC—systemic lupus erythematosus	3.62e-05	0.00732	CbGpPWpGaD
Pralatrexate—DHFR—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	3.6e-05	0.00729	CbGpPWpGaD
Pralatrexate—Abdominal pain—Methotrexate—systemic lupus erythematosus	3.6e-05	0.0019	CcSEcCtD
Pralatrexate—Body temperature increased—Methotrexate—systemic lupus erythematosus	3.6e-05	0.0019	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Prednisolone—systemic lupus erythematosus	3.54e-05	0.0233	CbGdCrCtD
Pralatrexate—TYMS—Danazol—Hydrocortisone—systemic lupus erythematosus	3.54e-05	0.0233	CbGdCrCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	3.53e-05	0.00715	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CSK—systemic lupus erythematosus	3.53e-05	0.00714	CbGpPWpGaD
Pralatrexate—TYMS—Budesonide—Methylprednisolone—systemic lupus erythematosus	3.49e-05	0.0229	CbGdCrCtD
Pralatrexate—TYMS—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	3.47e-05	0.00702	CbGpPWpGaD
Pralatrexate—Vomiting—Prednisone—systemic lupus erythematosus	3.46e-05	0.00183	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Betamethasone—systemic lupus erythematosus	3.43e-05	0.0225	CbGdCrCtD
Pralatrexate—TYMS—Budesonide—Dexamethasone—systemic lupus erythematosus	3.43e-05	0.0225	CbGdCrCtD
Pralatrexate—Rash—Prednisone—systemic lupus erythematosus	3.43e-05	0.00182	CcSEcCtD
Pralatrexate—Dermatitis—Prednisone—systemic lupus erythematosus	3.43e-05	0.00182	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Triamcinolone—systemic lupus erythematosus	3.35e-05	0.022	CbGdCrCtD
Pralatrexate—DHFR—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	3.32e-05	0.00673	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD247—systemic lupus erythematosus	3.31e-05	0.00671	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NAT2—systemic lupus erythematosus	3.31e-05	0.00671	CbGpPWpGaD
Pralatrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—systemic lupus erythematosus	3.3e-05	0.00669	CbGpPWpGaD
Pralatrexate—Asthenia—Methotrexate—systemic lupus erythematosus	3.26e-05	0.00173	CcSEcCtD
Pralatrexate—Nausea—Prednisone—systemic lupus erythematosus	3.23e-05	0.00171	CcSEcCtD
Pralatrexate—SLC19A1—Disease—NCF2—systemic lupus erythematosus	3.22e-05	0.00653	CbGpPWpGaD
Pralatrexate—Pruritus—Methotrexate—systemic lupus erythematosus	3.22e-05	0.0017	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Prednisone—systemic lupus erythematosus	3.18e-05	0.0209	CbGdCrCtD
Pralatrexate—DHFR—E2F transcription factor network—EP300—systemic lupus erythematosus	3.16e-05	0.0064	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	3.14e-05	0.00636	CbGpPWpGaD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	3.13e-05	0.00634	CbGpPWpGaD
Pralatrexate—Diarrhoea—Methotrexate—systemic lupus erythematosus	3.11e-05	0.00165	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Prednisolone—systemic lupus erythematosus	3.11e-05	0.0204	CbGdCrCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	3.1e-05	0.00626	CbGpPWpGaD
Pralatrexate—FPGS—Disease—HIST2H2AC—systemic lupus erythematosus	3.08e-05	0.00623	CbGpPWpGaD
Pralatrexate—TYMS—Danazol—Prednisone—systemic lupus erythematosus	3.05e-05	0.02	CbGdCrCtD
Pralatrexate—FPGS—Disease—CSK—systemic lupus erythematosus	3e-05	0.00607	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	2.9e-05	0.00587	CbGpPWpGaD
Pralatrexate—Vomiting—Methotrexate—systemic lupus erythematosus	2.89e-05	0.00153	CcSEcCtD
Pralatrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	2.89e-05	0.00585	CbGpPWpGaD
Pralatrexate—Rash—Methotrexate—systemic lupus erythematosus	2.87e-05	0.00152	CcSEcCtD
Pralatrexate—Dermatitis—Methotrexate—systemic lupus erythematosus	2.87e-05	0.00152	CcSEcCtD
Pralatrexate—FPGS—Disease—CD247—systemic lupus erythematosus	2.82e-05	0.00571	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NAT2—systemic lupus erythematosus	2.82e-05	0.0057	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	2.8e-05	0.00567	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—TNF—systemic lupus erythematosus	2.78e-05	0.00563	CbGpPWpGaD
Pralatrexate—TYMS—E2F transcription factor network—EP300—systemic lupus erythematosus	2.76e-05	0.00559	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NCF2—systemic lupus erythematosus	2.74e-05	0.00555	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	2.73e-05	0.00553	CbGpPWpGaD
Pralatrexate—Nausea—Methotrexate—systemic lupus erythematosus	2.7e-05	0.00143	CcSEcCtD
Pralatrexate—DHFR—G1/S Transition—CDKN1B—systemic lupus erythematosus	2.61e-05	0.00529	CbGpPWpGaD
Pralatrexate—TYMS—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	2.54e-05	0.0167	CbGdCrCtD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	2.54e-05	0.00513	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—JUNB—systemic lupus erythematosus	2.53e-05	0.00512	CbGpPWpGaD
Pralatrexate—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	2.52e-05	0.0051	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	2.51e-05	0.00507	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	2.44e-05	0.00495	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	2.44e-05	0.00495	CbGpPWpGaD
Pralatrexate—DHFR—G1/S Transition—CDKN1A—systemic lupus erythematosus	2.41e-05	0.00488	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—FAS—systemic lupus erythematosus	2.35e-05	0.00475	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PRL—systemic lupus erythematosus	2.33e-05	0.00472	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—CDKN1B—systemic lupus erythematosus	2.28e-05	0.00462	CbGpPWpGaD
Pralatrexate—DHFR—Folate Metabolism—IL6—systemic lupus erythematosus	2.25e-05	0.00455	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	2.2e-05	0.00446	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	2.19e-05	0.00442	CbGpPWpGaD
Pralatrexate—FPGS—Disease—JUNB—systemic lupus erythematosus	2.15e-05	0.00435	CbGpPWpGaD
Pralatrexate—TYMS—G1/S Transition—CDKN1A—systemic lupus erythematosus	2.1e-05	0.00426	CbGpPWpGaD
Pralatrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	2.03e-05	0.00411	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PRL—systemic lupus erythematosus	1.98e-05	0.00401	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	1.92e-05	0.00389	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—PPARG—systemic lupus erythematosus	1.88e-05	0.0038	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—JAK1—systemic lupus erythematosus	1.86e-05	0.00377	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—RXRA—systemic lupus erythematosus	1.86e-05	0.00376	CbGpPWpGaD
Pralatrexate—TYMS—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	1.77e-05	0.00359	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CCR5—systemic lupus erythematosus	1.77e-05	0.00358	CbGpPWpGaD
Pralatrexate—DHFR—Disease—XRCC6—systemic lupus erythematosus	1.74e-05	0.00353	CbGpPWpGaD
Pralatrexate—FPGS—Disease—JAK1—systemic lupus erythematosus	1.59e-05	0.00321	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—RXRA—systemic lupus erythematosus	1.58e-05	0.0032	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.54e-05	0.00311	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CCR5—systemic lupus erythematosus	1.5e-05	0.00304	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.46e-05	0.00295	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD80—systemic lupus erythematosus	1.45e-05	0.00294	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.34e-05	0.00272	CbGpPWpGaD
Pralatrexate—DHFR—Disease—HIST2H2AC—systemic lupus erythematosus	1.29e-05	0.0026	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.28e-05	0.00259	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CSK—systemic lupus erythematosus	1.25e-05	0.00253	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD80—systemic lupus erythematosus	1.24e-05	0.0025	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—EP300—systemic lupus erythematosus	1.23e-05	0.00248	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TYK2—systemic lupus erythematosus	1.23e-05	0.00248	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.21e-05	0.00245	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—NOS3—systemic lupus erythematosus	1.2e-05	0.00244	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD247—systemic lupus erythematosus	1.18e-05	0.00238	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NAT2—systemic lupus erythematosus	1.18e-05	0.00238	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PPARG—systemic lupus erythematosus	1.17e-05	0.00237	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NCF2—systemic lupus erythematosus	1.15e-05	0.00232	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.11e-05	0.00225	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CD4—systemic lupus erythematosus	1.11e-05	0.00225	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—PTGS2—systemic lupus erythematosus	1.1e-05	0.00223	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—ALB—systemic lupus erythematosus	1.05e-05	0.00213	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TYK2—systemic lupus erythematosus	1.04e-05	0.00211	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1B—systemic lupus erythematosus	1.04e-05	0.00211	CbGpPWpGaD
Pralatrexate—TYMS—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.04e-05	0.0021	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NAT2—systemic lupus erythematosus	1.03e-05	0.00208	CbGpPWpGaD
Pralatrexate—FPGS—Disease—NOS3—systemic lupus erythematosus	1.02e-05	0.00207	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—NOS3—systemic lupus erythematosus	1.01e-05	0.00204	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PPARG—systemic lupus erythematosus	9.97e-06	0.00202	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—CDKN1A—systemic lupus erythematosus	9.63e-06	0.00195	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CD4—systemic lupus erythematosus	9.43e-06	0.00191	CbGpPWpGaD
Pralatrexate—FPGS—Disease—PTGS2—systemic lupus erythematosus	9.37e-06	0.0019	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—PTGS2—systemic lupus erythematosus	9.22e-06	0.00187	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—EP300—systemic lupus erythematosus	9.16e-06	0.00185	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JUNB—systemic lupus erythematosus	8.99e-06	0.00182	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—ALB—systemic lupus erythematosus	8.97e-06	0.00181	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1B—systemic lupus erythematosus	8.87e-06	0.0018	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—NOS3—systemic lupus erythematosus	8.58e-06	0.00174	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PRL—systemic lupus erythematosus	8.28e-06	0.00168	CbGpPWpGaD
Pralatrexate—FPGS—Disease—CDKN1A—systemic lupus erythematosus	8.19e-06	0.00166	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	8.08e-06	0.00164	CbGpPWpGaD
Pralatrexate—TYMS—Circadian rythm related genes—IL6—systemic lupus erythematosus	8.04e-06	0.00163	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—TGFB1—systemic lupus erythematosus	7.96e-06	0.00161	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—PTGS2—systemic lupus erythematosus	7.84e-06	0.00159	CbGpPWpGaD
Pralatrexate—FPGS—Disease—EP300—systemic lupus erythematosus	7.79e-06	0.00158	CbGpPWpGaD
Pralatrexate—SLC19A1—Metabolism—EP300—systemic lupus erythematosus	7.67e-06	0.00155	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	7.45e-06	0.00151	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1B—systemic lupus erythematosus	7.22e-06	0.00146	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	7.09e-06	0.00144	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	7.05e-06	0.00143	CbGpPWpGaD
Pralatrexate—FPGS—Disease—TGFB1—systemic lupus erythematosus	6.77e-06	0.00137	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—CDKN1A—systemic lupus erythematosus	6.67e-06	0.00135	CbGpPWpGaD
Pralatrexate—DHFR—Disease—JAK1—systemic lupus erythematosus	6.62e-06	0.00134	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—RXRA—systemic lupus erythematosus	6.6e-06	0.00134	CbGpPWpGaD
Pralatrexate—FPGS—Metabolism—EP300—systemic lupus erythematosus	6.52e-06	0.00132	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	6.51e-06	0.00132	CbGpPWpGaD
Pralatrexate—DHFR—Cell Cycle—EP300—systemic lupus erythematosus	6.34e-06	0.00128	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1B—systemic lupus erythematosus	6.3e-06	0.00128	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CCR5—systemic lupus erythematosus	6.28e-06	0.00127	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	6.19e-06	0.00125	CbGpPWpGaD
Pralatrexate—SLC19A1—Disease—IL6—systemic lupus erythematosus	6e-06	0.00121	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—CDKN1A—systemic lupus erythematosus	5.82e-06	0.00118	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—RXRA—systemic lupus erythematosus	5.76e-06	0.00117	CbGpPWpGaD
Pralatrexate—TYMS—Cell Cycle—EP300—systemic lupus erythematosus	5.53e-06	0.00112	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD80—systemic lupus erythematosus	5.16e-06	0.00104	CbGpPWpGaD
Pralatrexate—FPGS—Disease—IL6—systemic lupus erythematosus	5.1e-06	0.00103	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TYK2—systemic lupus erythematosus	4.36e-06	0.000882	CbGpPWpGaD
Pralatrexate—DHFR—Disease—NOS3—systemic lupus erythematosus	4.28e-06	0.000866	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PPARG—systemic lupus erythematosus	4.16e-06	0.000843	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CD4—systemic lupus erythematosus	3.94e-06	0.000798	CbGpPWpGaD
Pralatrexate—DHFR—Disease—PTGS2—systemic lupus erythematosus	3.91e-06	0.000792	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—ALB—systemic lupus erythematosus	3.75e-06	0.000758	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1B—systemic lupus erythematosus	3.71e-06	0.00075	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PPARG—systemic lupus erythematosus	3.63e-06	0.000736	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—NOS3—systemic lupus erythematosus	3.58e-06	0.000725	CbGpPWpGaD
Pralatrexate—DHFR—Disease—CDKN1A—systemic lupus erythematosus	3.42e-06	0.000692	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—PTGS2—systemic lupus erythematosus	3.28e-06	0.000663	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—ALB—systemic lupus erythematosus	3.27e-06	0.000661	CbGpPWpGaD
Pralatrexate—DHFR—Disease—EP300—systemic lupus erythematosus	3.25e-06	0.000659	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—NOS3—systemic lupus erythematosus	3.13e-06	0.000633	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—PTGS2—systemic lupus erythematosus	2.86e-06	0.000579	CbGpPWpGaD
Pralatrexate—DHFR—Disease—TGFB1—systemic lupus erythematosus	2.83e-06	0.000572	CbGpPWpGaD
Pralatrexate—DHFR—Metabolism—EP300—systemic lupus erythematosus	2.72e-06	0.000552	CbGpPWpGaD
Pralatrexate—TYMS—Metabolism—EP300—systemic lupus erythematosus	2.38e-06	0.000481	CbGpPWpGaD
Pralatrexate—DHFR—Disease—IL6—systemic lupus erythematosus	2.13e-06	0.000431	CbGpPWpGaD
